NanoString Technologies Inc (NSTGQ)
0.1133
-0.05
(-31.04%)
USD |
OTCM |
May 08, 15:01
NanoString Technologies Debt to Equity Ratio: -4.504 for Sept. 30, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2023 | -4.504 |
| June 30, 2023 | -10.60 |
| March 31, 2023 | 16.67 |
| December 31, 2022 | 4.947 |
| September 30, 2022 | 2.728 |
| June 30, 2022 | 2.005 |
| March 31, 2022 | 1.552 |
| December 31, 2021 | 1.272 |
| September 30, 2021 | 1.129 |
| June 30, 2021 | 1.021 |
| March 31, 2021 | 0.9479 |
| December 31, 2020 | 0.5626 |
| September 30, 2020 | 1.657 |
| June 30, 2020 | 1.459 |
| March 31, 2020 | 1.219 |
| December 31, 2019 | 0.7676 |
| September 30, 2019 | 1.091 |
| June 30, 2019 | 0.9122 |
| March 31, 2019 | 0.6229 |
| December 31, 2018 | 1.584 |
| September 30, 2018 | 0.9625 |
| June 30, 2018 | 5.770 |
| Date | Value |
|---|---|
| March 31, 2018 | 1.972 |
| December 31, 2017 | 1.22 |
| September 30, 2017 | 1.077 |
| June 30, 2017 | 0.9253 |
| March 31, 2017 | -15.62 |
| December 31, 2016 | 3.849 |
| September 30, 2016 | -7.166 |
| June 30, 2016 | 140.35 |
| March 31, 2016 | 4.796 |
| December 31, 2015 | 2.025 |
| September 30, 2015 | 1.162 |
| June 30, 2015 | 0.9238 |
| March 31, 2015 | 0.976 |
| December 31, 2014 | 0.6636 |
| September 30, 2014 | 0.3726 |
| June 30, 2014 | 0.3069 |
| March 31, 2014 | 0.2201 |
| December 31, 2013 | 0.5813 |
| September 30, 2013 | 0.3461 |
| June 30, 2013 | -8.73 |
| March 31, 2013 | 1.790 |
| December 31, 2012 | 1.294 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-10.60
Minimum
Jun 2023
16.67
Maximum
Mar 2023
1.380
Average
1.174
Median
Debt to Equity Ratio Benchmarks
| Bruker Corp | 0.962 |
| Azenta Inc | 0.00 |
| Harvard Bioscience Inc | 0.5004 |
| Bionano Genomics Inc | 0.7259 |
| Akoya Biosciences Inc | 1.400 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 274.71M |
| Total Liabilities (Quarterly) | 325.28M |
| Shareholders Equity (Quarterly) | -50.57M |
| Current Ratio | 2.732 |
| Net Debt Paydown Yield | -0.46% |